Functional proteomics revealed IL-1β amplifies TNF downstream protein signals in human synoviocytes in a TNF-independent manner

Biochemical and Biophysical Research Communications

Volumn 450, Issue 1, 2014, Pages 538-544

  Shen, Shan ^a,b   Guo, Jiahui ^b   Luo, Yanzhang ^b   Zhang, Wanling ^b   Cui, Yizhi ^b   Wang, Qing ^b   Zhang, Zhiguang ^a   Wang, Tong ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

IL 1 ; p62; Proteomics; Synoviocytes; TNF independent

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN P62; PROTEOME; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FIBROBLAST LIKE SYNOVIOCYTE; FRACTURE SYNOVITIS; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM; UPREGULATION;

IL-1Β; P62; PROTEOMICS; SYNOVIOCYTES; TNF-INDEPENDENT;

BIOLOGICAL MARKERS; CELLS, CULTURED; HUMANS; INTERLEUKIN-1BETA; PROTEOME; RNA-BINDING PROTEINS; SYNOVIAL MEMBRANE; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904750386     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.06.008     Document Type: Article

References (33)

1. T. Wang, N. Gong, J. Liu, I. Kadiu, S.D. Kraft-Terry, J.D. Schlautman, P. Ciborowski, D.J. Volsky, and H.E. Gendelman HIV-1-infected astrocytes and the microglial proteome J. Neuroimmune. Pharmacol. 3 2008 173 186
2. T. Wang, N. Gong, J. Liu, I. Kadiu, S.D. Kraft-Terry, R.L. Mosley, D.J. Volsky, P. Ciborowski, and H.E. Gendelman Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk PLoS One 3 2008 e2507
3. J.A. Hutter-Saunders, R.L. Mosley, and H.E. Gendelman Pathways towards an effective immunotherapy for Parkinson's disease Expert Rev. Neurother. 11 2011 1703 1715
4. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
5. M. Chabaud, P. Garnero, J.M. Dayer, P.A. Guerne, F. Fossiez, and P. Miossec Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis Cytokine 12 2000 1092 1099
6. W. Hueber, B.H. Tomooka, X. Zhao, B.A. Kidd, J.W. Drijfhout, J.F. Fries, W.J. van Venrooij, A.L. Metzger, M.C. Genovese, and W.H. Robinson Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines Ann. Rheum. Dis. 66 2007 712 719
7. R.M. Chakr, J.A. Mendonca, C.V. Brenol, R.M. Xavier, and J.C. Brenol Assessing rheumatoid arthritis disease activity with ultrasound Clin. Rheumatol. 32 2013 1249 1254
8. C.R. Scanzello, and S.R. Goldring The role of synovitis in osteoarthritis pathogenesis Bone 51 2012 249 257
9. D.F. Remst, A.B. Blom, E.L. Vitters, R.A. Bank, W.B. van den Berg, E.N. Blaney Davidson, and P.M. van der Kraan Gene expression analysis of murine and human osteoarthritis synovium reveals elevation of transforming growth factor beta-responsive genes in osteoarthritis-related fibrosis Arthritis Rheumatol. 66 2014 647 656
10. Y. Tanaka The role of chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis Drugs Today (Barc.) 37 2001 477 484
11. H.M. Choi, H. Oh da, J.S. Bang, H.I. Yang, M.C. Yoo, and K.S. Kim Differential effect of IL-1beta and TNFalpha on the production of IL-6, IL-8 and PGE2 in fibroblast-like synoviocytes and THP-1 macrophages Rheumatol. Int. 30 2010 1025 1033
12. X. Zeng, T. Wang, C. Zhu, X. Xing, Y. Ye, X. Lai, B. Song, and Y. Zeng Topographical and biological evidence revealed FTY720-mediated anergy-polarization of mouse bone marrow-derived dendritic cells in vitro PLoS One 7 2012 e34830
13. T. Wang, Y. Cui, J. Jin, J. Guo, G. Wang, X. Yin, Q.Y. He, and G. Zhang Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific Nucleic Acids Res. 41 2013 4743 4754
14. L.P. Li, C.H. Lu, Z.P. Chen, F. Ge, T. Wang, W. Wang, C.L. Xiao, X.F. Yin, L. Liu, J.X. He, and Q.Y. He Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer Proteomics 11 2011 429 439
15. J.Y. Choe, H.Y. Jung, K.Y. Park, and S.K. Kim Enhanced p62 expression through impaired proteasomal degradation is involved in caspase-1 activation in monosodium urate crystal-induced interleukin-1beta expression Rheumatology (Oxford) 2014
16. D. van der Heijde, L. Klareskog, R. Landewe, G.A. Bruyn, A. Cantagrel, P. Durez, G. Herrero-Beaumont, Y. Molad, C. Codreanu, G. Valentini, R. Zahora, R. Pedersen, D. MacPeek, J. Wajdula, and S. Fatenejad Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis Arthritis Rheum. 56 2007 3928 3939
17. K.L. Hyrich, C. Deighton, K.D. Watson, B.C.C. Consortium, D.P. Symmons, M. Lunt, and R. British Society for Rheumatology Biologics Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity Rheumatology (Oxford) 48 2009 1323 1327
18. J. Augustsson, M. Neovius, C. Cullinane-Carli, S. Eksborg, and R.F. van Vollenhoven Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry) Ann. Rheum. Dis. 69 2010 126 131
19. T. Suzuki, M. Horikoshi, M. Sugihara, T. Hirota, H. Ogishima, N. Umeda, Y. Kondo, H. Tsuboi, T. Hayashi, Y. Chino, I. Matsumoto, and T. Sumida Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI Mod. Rheumatol. 23 2013 782 787
20. J. Youn Regulation of TNF-α-mediated hyperplasia through TNF receptors, TRAFs, and NF-κB in synoviocytes obtained from patients with rheumatoid arthritis Immunol. Lett. 83 2002 85 93
21. E.A. Moelants, A. Mortier, J. Van Damme, and P. Proost Regulation of TNF-alpha with a focus on rheumatoid arthritis Immunol. Cell Biol. 91 2013 393 401
22. J.C. Jones Carcinoma of the lung Calif. Med. 68 1948 305 307
23. Y.R. Lee, J.K. Hwang, H.S. Lee, Y.J. Cheon, J.H. Ryu, S.I. Lee, H.B. Kwak, S.M. Lee, J.S. Kim, J.W. Park, R. Jeon, and B.H. Park SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis Br. J. Pharmacol. 164 2011 794 806
24. E.C. Keystone, F.C. Breedveld, D. van der Heijde, R. Landewe, S. Florentinus, U. Arulmani, S. Liu, H. Kupper, and A. Kavanaugh Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension J. Rheumatol. 41 2014 5 14
25. T. Suzuki, S. Ito, S. Handa, K. Kose, Y. Okamoto, M. Minami, T. Hayashi, D. Goto, I. Matsumoto, and T. Sumida A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis Mod. Rheumatol. 19 2009 358 365
26. L. Quartuccio, M. Fabris, S. Salvin, F. Atzeni, M. Saracco, M. Benucci, M. Cimmino, P. Morassi, P. Masolini, R. Pellerito, M. Cutolo, P.S. Puttini, and S. De Vita Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis Rheumatology (Oxford) 48 2009 1557 1559
27. M. Haroon, and D. O'Gradaigh Efficacy and safety of combining intra-articular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory monoarthritis Joint Bone Spine 77 2010 232 234
28. I.K. Campbell, K. O'Donnell, K.E. Lawlor, and I.P. Wicks Severe inflammatory arthritis and lymphadenopathy in the absence of TNF J. Clin. Invest. 107 2001 1519 1527
29. J.P. Pelletier, J.P. Caron, C. Evans, P.D. Robbins, H.I. Georgescu, D. Jovanovic, J.C. Fernandes, and J. Martel-Pelletier In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy Arthritis Rheum. 40 1997 1012 1019
30. S. You, S.A. Yoo, S. Choi, J.Y. Kim, S.J. Park, J.D. Ji, T.H. Kim, K.J. Kim, C.S. Cho, D. Hwang, and W.U. Kim Identification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach Proc. Natl. Acad. Sci. U.S.A. 111 2014 550 555
31. S. Chen, Y. Yang, H. Feng, H. Wang, R. Zhao, and H. Liu Baicalein inhibits interleukin-1beta-induced proliferation of human rheumatoid arthritis fibroblast-like synoviocytes Inflammation 37 2014 163 169
32. J. Lee, H.R. Kim, C. Quinley, J. Kim, J. Gonzalez-Navajas, R. Xavier, and E. Raz Autophagy suppresses interleukin-1beta (IL-1beta) signaling by activation of p62 degradation via lysosomal and proteasomal pathways J. Biol. Chem. 287 2012 4033 4040
33. J. Xu, H.F. Wu, E.S. Ang, K. Yip, M. Woloszyn, M.H. Zheng, and R.X. Tan NF-kappaB modulators in osteolytic bone diseases Cytokine Growth Factor Rev. 20 2009 7 17